Newtyn Management, LLC - Q2 2022 holdings

$528 Million is the total value of Newtyn Management, LLC's 84 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 130.8% .

 Value Shares↓ Weighting
PAR BuyPAR TECHNOLOGY CORP$38,167,000
+26.2%
1,018,068
+35.7%
7.23%
-0.2%
BuyARDAGH METAL PACKAGING S A$36,753,000
+100.9%
6,025,000
+167.8%
6.96%
+59.0%
BCOR BuyBLUCORA INC$32,275,000
+10.1%
1,748,389
+16.6%
6.12%
-12.9%
BuyORION OFFICE REIT INC$30,250,000
+39.4%
2,760,000
+78.1%
5.73%
+10.3%
CNNE NewCANNAE HLDGS INC$27,076,0001,400,000
+100.0%
5.13%
IAC NewIAC INTERACTIVECORP NEW$25,450,000335,000
+100.0%
4.82%
SPB  SPECTRUM BRANDS HLDGS INC NE$20,500,000
-7.5%
249,9370.0%3.88%
-26.9%
MBI BuyMBIA INC$19,548,000
-7.8%
1,582,811
+14.8%
3.70%
-27.1%
GTXAP SellGARRETT MOTION INCpfd conv ser a$19,030,000
-9.8%
2,315,058
-9.2%
3.60%
-28.6%
TBPH BuyTHERAVANCE BIOPHARMA INC$18,463,000
+40.5%
2,037,825
+48.2%
3.50%
+11.1%
Sell2SEVENTY BIO INC$17,778,000
-34.4%
1,346,796
-15.2%
3.37%
-48.1%
CIO BuyCITY OFFICE REIT INC$14,180,000
-11.1%
1,095,000
+21.3%
2.69%
-29.6%
SellALGOMA STL GROUP INC$13,470,000
-32.5%
1,500,000
-15.4%
2.55%
-46.6%
PFSW BuyPFSWEB INC$13,306,000
+16.4%
1,131,505
+13.2%
2.52%
-7.9%
ADNT SellADIENT PLC$12,483,000
-28.8%
421,293
-2.0%
2.36%
-43.7%
EPZM NewEPIZYME INC$11,128,0007,569,995
+100.0%
2.11%
 FORUM ENERGY TECHNOLOGIES INnote 9.000% 8/0$11,126,000
-1.9%
11,500,0000.0%2.11%
-22.4%
LW NewLAMB WESTON HLDGS INC$10,719,000150,000
+100.0%
2.03%
MACK BuyMERRIMACK PHARMACEUTICALS IN$10,460,000
-3.4%
1,758,005
+2.6%
1.98%
-23.6%
GLPG BuyGALAPAGOS NVspon adr$9,486,000
+34.9%
170,000
+49.9%
1.80%
+6.7%
VTOL BuyBRISTOW GROUP INC$9,331,000
-36.3%
398,745
+1.0%
1.77%
-49.6%
PCG SellPG&E CORP$8,383,000
-46.0%
840,000
-35.4%
1.59%
-57.3%
NODK  NI HLDGS INC$7,229,000
-3.1%
440,0000.0%1.37%
-23.3%
AMPY BuyAMPLIFY ENERGY CORP NEW$7,031,000
+24.7%
1,075,000
+4.9%
1.33%
-1.3%
LQDA NewLIQUIDIA CORPORATION$6,839,0001,568,627
+100.0%
1.30%
VRTS NewVIRTUS INVT PARTNERS INC$6,755,00039,500
+100.0%
1.28%
KOD NewKODIAK SCIENCES INC$5,539,000725,000
+100.0%
1.05%
CUBI  CUSTOMERS BANCORP INC$5,085,000
-35.0%
150,0000.0%0.96%
-48.6%
QURE NewUNIQURE NV$5,072,000272,091
+100.0%
0.96%
TLYS BuyTILLYS INCcl a$4,352,000
-7.0%
620,000
+24.0%
0.82%
-26.4%
NHF SellNEXPOINT DIVERSIFIED REL ET$4,123,000
-13.1%
250,000
-16.7%
0.78%
-31.2%
SFIX BuySTITCH FIX INC$4,076,000
+34.9%
825,000
+175.0%
0.77%
+6.8%
RDUS NewRADIUS HEALTH INC$3,961,000381,998
+100.0%
0.75%
RLJPRA SellRLJ LODGING TRcum conv pfd a$3,257,000
-68.9%
125,607
-66.9%
0.62%
-75.4%
DXLG SellDESTINATION XL GROUP INC$3,051,000
-38.4%
900,000
-11.3%
0.58%
-51.3%
DNMR BuyDANIMER SCIENTIFIC INC$2,850,000
-2.7%
625,000
+25.0%
0.54%
-23.1%
IVAC BuyINTEVAC INC$2,440,000
+14.0%
504,035
+26.0%
0.46%
-9.8%
CIX SellCOMPX INTL INCcl a$2,319,000
-36.2%
100,000
-35.3%
0.44%
-49.6%
PHAT NewPHATHOM PHARMACEUTICALS INC$2,159,000255,767
+100.0%
0.41%
OLMA NewOLEMA PHARMACEUTICALS INC$2,035,000500,000
+100.0%
0.39%
TCRR NewTCR2 THERAPEUTICS INC$2,009,000692,799
+100.0%
0.38%
CTMX NewCYTOMX THERAPEUTICS INC$1,964,0001,073,400
+100.0%
0.37%
NewPYXIS ONCOLOGY INC$1,904,000800,000
+100.0%
0.36%
COLL NewCOLLEGIUM PHARMACEUTICAL INC$1,861,000105,000
+100.0%
0.35%
CYT NewCYTEIR THERAPEUTICS INC$1,813,000606,248
+100.0%
0.34%
FVE  ALERISLIFE INC$1,800,000
-44.2%
1,500,0000.0%0.34%
-55.8%
ATAI BuyATAI LIFE SCIENCES NV$1,711,000
+34.4%
470,000
+87.9%
0.32%
+6.2%
LTCH BuyLATCH INC$1,710,000
-39.0%
1,500,000
+128.6%
0.32%
-51.7%
NewGLOBAL BUSINESS TRAVEL GROUP$1,547,000245,208
+100.0%
0.29%
BOLT NewBOLT BIOTHERAPEUTICS INC$1,526,000748,252
+100.0%
0.29%
PASG NewPASSAGE BIO INC$1,463,000620,000
+100.0%
0.28%
BuySEMA4 HOLDINGS CORP$1,443,000
-21.7%
1,145,000
+90.8%
0.27%
-38.1%
NewADAGIO THERAPEUTICS INC$1,315,000400,875
+100.0%
0.25%
WVE NewWAVE LIFE SCIENCES LTD$1,312,000403,553
+100.0%
0.25%
DBTX NewDECIBEL THERAPEUTICS INC$1,305,000310,000
+100.0%
0.25%
BDTX NewBLACK DIAMOND THERAPEUTICS I$1,279,000520,000
+100.0%
0.24%
ADVM NewADVERUM BIOTECHNOLOGIES INC$1,242,0001,035,000
+100.0%
0.24%
ALGS NewALIGOS THERAPEUTICS INC$1,164,000962,088
+100.0%
0.22%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$1,159,000105,000
+100.0%
0.22%
ALEC NewALECTOR INC$1,067,000105,000
+100.0%
0.20%
ETNB New89BIO INC$998,000310,000
+100.0%
0.19%
EAR SellEARGO INC$987,000
-90.4%
1,312,066
-32.7%
0.19%
-92.4%
SNSE NewSENSEI BIOTHERAPEUTICS INC$942,000415,000
+100.0%
0.18%
AMR  ALPHA METALLURGICAL RESOUR I$816,000
-2.2%
6,3190.0%0.16%
-22.5%
NewTSCAN THERAPEUTICS INC$782,000248,611
+100.0%
0.15%
QD NewQUDIAN INCadr$759,000690,290
+100.0%
0.14%
NUVB NewNUVATION BIO INC$680,000210,000
+100.0%
0.13%
ORIC NewORIC PHARMACEUTICALS INC$672,000150,000
+100.0%
0.13%
RFL SellRAFAEL HLDGS INC$561,000
-44.0%
300,000
-24.8%
0.11%
-55.8%
SIOX NewSIO GENE THERAPIES INC$510,0001,415,859
+100.0%
0.10%
KRON NewKRONOS BIO INC$461,000126,623
+100.0%
0.09%
NewDOMA HOLDINGS INC$309,000300,000
+100.0%
0.06%
TLIS NewTALIS BIOMEDICAL CORP$231,000284,726
+100.0%
0.04%
AMYT NewAMRYT PHARMA PLCsponsored ads$207,00029,656
+100.0%
0.04%
BCAB NewBIOATLA INC$186,00065,332
+100.0%
0.04%
New8I ACQUISITION 2 CORPright 09/24/2026$173,000750,000
+100.0%
0.03%
SATS NewECHOSTAR CORPcl a$152,0007,862
+100.0%
0.03%
AGBAR NewAGBA ACQUISITION LTDright 05/10/2024$70,000500,000
+100.0%
0.01%
RPHM NewRENEO PHARMACEUTICALS INC$56,00020,983
+100.0%
0.01%
BRLIR NewBRILLIANT ACQUISITION CORPright 99/99/9999$60,000457,409
+100.0%
0.01%
BENER NewBENESSERE CAPITAL ACQUSTN COright 99/99/9999$38,000250,000
+100.0%
0.01%
NewARISZ ACQUISITION CORPright 99/99/9999$25,000250,000
+100.0%
0.01%
VHAQRT NewVIVEON HEALTH ACQUISITION COright 12/31/2025$20,000250,000
+100.0%
0.00%
NewSPK AQUISITION CORPright 05/13/2026$1,00060,000
+100.0%
0.00%
ExitLEAFLY HOLDINGS INC*w exp 11/07/202$0-100,000
-100.0%
-0.03%
ExitEMBECTA CORP$0-21,366
-100.0%
-0.17%
ExitLOYALTY VENTURES INC$0-573,704
-100.0%
-2.27%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC27Q3 20232.9%
ADIENT PLC26Q1 202317.3%
MERRIMACK PHARMACEUTICALS IN25Q3 20235.7%
PG&E CORP24Q3 202319.2%
SPECTRUM BRANDS HLDGS INC NE21Q3 20236.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC14Q3 20234.8%
APPLIED OPTOELECTRONICS INC14Q3 20212.2%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%
Flexion Therapeutics IncNovember 24, 20214,400,0008.7%
FLOTEK INDUSTRIES INC/CN/February 16, 20212,789,0593.8%
Forward Pharma A/SSold outFebruary 16, 202100.0%
Pfenex Inc.October 02, 2020650,0001.9%
CymaBay Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Recro Pharma, Inc.Sold outFebruary 14, 202000.0%
Stable Road Acquisition Corp.February 14, 2020700,0003.9%
CSW INDUSTRIALS, INC.February 14, 2017330,0002.1%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13D/A2024-02-13
SC 13D/A2024-01-25

View Newtyn Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (527822000.0 != 527825000.0)

Export Newtyn Management, LLC's holdings